Case Report
Copyright ©2013 Baishideng Publishing Group Co.
World J Hepatol. Oct 27, 2013; 5(10): 596-600
Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.596
Figure 1
Figure 1 Clinical course of the 60-year-old female patient with stage IVB hepatocellular carcinoma (HCC). A: The change of tumor markers; B: After 3 mo of MK615 treatment, the lymph node metastasis decreased in size from 30-13 mm in diameter; C: Three months after the MK615 treatment, the lung metastasis was decreased in size from 20-7 mm in diameter. AFP: Alpha-fetoprotein.
Figure 2
Figure 2 Serial changes in the alpha-fetoprotein levels in the 6 patients during the course of MK615 treatment. AFP: alpha-fetoprotein